IUI vs IVF in India: Costs, Success Rates and When to Step Up

• IUI (intrauterine insemination) places washed sperm directly into the uterus around ovulation. IVF (in-vitro fertilisation) retrieves eggs and creates embryos in a lab, then transfers them to the uterus.
• IUI suits younger couples with open tubes, reasonable sperm and mild issues. IVF is first-line when tubes are blocked, sperm quality is poor, ovarian reserve is low, or age means time is short.
• Per cycle, IVF success is roughly 2–3 times higher than IUI in good candidates — and the gap widens with age and with diagnoses like blocked tubes or severe male factor.
• In India in 2026, an IUI cycle typically costs Rs 15,000–30,000 and an IVF cycle Rs 1.5–3.5 lakh — a roughly 1:10 ratio, but multi-cycle IUI can quietly add up to the cost of IVF.
• Set a clear IUI ceiling (usually 3–4 cycles, fewer over 37) at the start of treatment. Drifting cycle by cycle is a common and costly trap.
• The right choice depends on your age, AMH, semen analysis, tubal status and budget — not on which method sounds more 'natural'.

Intrauterine insemination (IUI) is a simple, office-based procedure. A semen sample (from your partner or a donor) is washed and concentrated in the embryology lab, then placed directly into the uterine cavity through a thin catheter at the time of ovulation. The procedure takes minutes, is usually painless, and you can resume normal activity within an hour. IUI is almost always combined with ovulation induction using oral letrozole or clomiphene — and occasionally low-dose injectable gonadotropins — to fine-tune timing and give one or two eggs the best chance of meeting the sperm.

A full IUI cycle, from start to pregnancy test, takes about 4–5 weeks. Medications begin on day 2–3 of the cycle, monitoring scans confirm follicle growth around day 9–12, a trigger shot is given when the lead follicle reaches 18–20 mm, and IUI is performed 24–36 hours later, followed by the two-week wait to a pregnancy test.

In-vitro fertilisation (IVF) is a much more involved medical project. Instead of relying on natural fertilisation inside the body, IVF retrieves eggs surgically from the ovaries, fertilises them in the lab (using intracytoplasmic sperm injection — ICSI — when sperm quality is borderline or poor), cultures the resulting embryos for 3–5 days, and transfers one or two back into the uterus. The cycle requires 8–12 days of daily injectable hormones to grow multiple follicles, monitoring scans every 2–3 days, an under-sedation egg retrieval, a capable embryology lab, and an embryo transfer in clinic. A fresh cycle takes 4–6 weeks; with a freeze-all strategy, the transfer happens in a separate later cycle, adding around four weeks.

The core difference decides who each treatment suits. IUI assists conception inside a body that is otherwise capable of it — so it needs open tubes, reasonable ovulation (often achievable with medication), and reasonable sperm quality. IVF bypasses many natural barriers entirely, which makes it the right choice when tubes are blocked, sperm quality is too low for natural fertilisation, ovarian reserve is limited and time is precious, or when years of trying and IUI have not worked.

Both treatments share a common foundation. Both need a baseline workup — AMH and antral follicle count, semen analysis with morphology, an HSG to confirm the tubes are open, thyroid and prolactin, and infectious-disease screening for both partners. Both involve monitoring scans during the stimulated cycle, both require luteal-phase progesterone support afterwards, and both end in that hard two-week wait. The differences lie in stimulation intensity, lab work, procedural complexity and cost — not in the surrounding workup or the emotional landscape.

Per-cycle live birth rates differ substantially between IUI and IVF, and both depend strongly on age and diagnosis. For IUI with ovulation induction in good Indian centres, per-cycle live birth runs roughly: 15–20% under 35 with unexplained infertility or mild PCOS; 10–15% at 35–37; 5–10% at 38–40; and 2–5% over 40 with own eggs. Cumulative live birth across 3–6 IUI cycles in women under 35 reaches roughly 40–50% for good candidates — but it plateaus sharply after 4–6 cycles, so additional IUI beyond that point adds very little.

Per-cycle live birth for own-egg IVF in good Indian centres runs higher: about 40–50% under 30, 35–45% at 30–34, 25–35% at 35–37, 15–25% at 38–40, 8–15% at 41–42, and 3–8% over 42. Cumulative live birth across three IVF cycles roughly doubles those single-cycle numbers in younger women — around 60–70% by cycle 3 under 35, dropping to 25–40% at 38–40 and 15–25% over 42. The per-cycle gap between IUI and IVF is roughly 2–3x in good candidates and widens further with age and with diagnoses where IUI essentially cannot work.

These numbers translate into very different decisions. A 30-year-old with unexplained infertility, a normal HSG and a normal semen analysis can reasonably try 3–4 IUI cycles before stepping up, because the time and money spent are not catastrophic and IVF remains a viable backup. A 38-year-old with low AMH should usually skip IUI or limit it to 1–2 cycles, because each passing month reduces both ovarian reserve and per-cycle IVF success — here, the time IUI consumes costs more than the money IVF requires. A 32-year-old with both tubes blocked has essentially zero IUI potential, because the sperm and egg cannot meet — IVF is the only option.

The two success curves also have different shapes. IUI success per cycle is roughly constant for the first 3–4 cycles in good-prognosis patients, then drops; the women most likely to conceive on IUI usually do so in the first three cycles. IVF success per cycle stays roughly constant across the first three cycles (and may rise slightly as protocols are refined), so cumulative success climbs more linearly. A practical rule: if your first IUI cycle showed good response but no pregnancy, two or three more cycles are reasonable; if the first cycle had poor response, moving to IVF is often the better next step than persisting.

IUI works best in specific profiles. The strongest candidates are women under 35 with unexplained infertility (normal HSG, ovulation on medication, normal semen analysis); women with mild ovulation issues that respond to letrozole or clomiphene, such as mild PCOS without other factors; couples with mild male factor (total motile count above 10 million after wash); women with cervical-factor infertility (a clean IUI indication, because the procedure bypasses the cervix); and single women or couples using donor sperm with no female factor.

IUI is also a sensible stepping-stone for younger couples who want to try the less invasive option first — particularly when finances are tight or emotional readiness for IVF is not yet there. The case for 3–4 IUI cycles in good candidates is reasonable: the cycle is far easier to live through (one office visit, one trigger injection, no sedation, no surgical retrieval), the cost is about one-tenth of IVF, and cumulative success at four cycles reaches 40–50% in good-prognosis under-35 patients. Importantly, trying IUI first leaves IVF entirely intact as the next step.

Donor sperm IUI is a common and successful pathway in its own right — used for single women eligible under the ART Act, couples with severe male factor where the husband cannot contribute viable sperm, and couples where the male partner carries a serious genetic condition. Donor sperm in India costs roughly Rs 15,000–30,000 per straw from licensed banks, with the donor IUI cycle adding Rs 15,000–25,000. Because donor sperm is pre-screened for quality, success in women under 35 is typically higher than husband-sperm IUI in mild male-factor couples — roughly 15–25% per cycle with cumulative 50–65% over 4–6 cycles.

One more niche worth knowing: timed natural-cycle IUI without ovulation induction, for women with regular ovulatory cycles whose indication is a cervical-mucus problem or mildly sub-fertile sperm. It follows natural ovulation with LH-surge tracking (urine ovulation kits or serial scans), then performs IUI at the right window. Success is lower per cycle (around 8–12%) but the cycle is gentler — no medications, no side effects — and cheaper (roughly Rs 8,000–15,000). It suits younger women with a clear cervical factor and an otherwise normal workup who want the lightest possible intervention first.

Several diagnostic and demographic profiles make IUI essentially futile, with IVF the only reasonable first-line option. These include both tubes blocked on HSG or laparoscopy (sperm and egg cannot meet); severe male factor infertility (count below 5 million/mL, severe motility or morphology problems); female age over 40 (per-cycle IUI drops below 5% while IVF still offers 8–15%, and the time-cost of multiple IUI cycles is biologically expensive); low AMH below 0.5–0.7 (you do not have time to spend on multi-cycle IUI); and any couple with two or more failed IUI cycles despite good response and timing.

Other reasons to skip straight to IVF include severe (stage 3–4) endometriosis affecting fertility, where IUI outcomes are very poor; prior tubal surgery or ectopic pregnancy (elevated repeat-ectopic risk); the need for preimplantation genetic testing (PGT-A for chromosomal screening, PGT-M for a known genetic disease, or PGT-SR for chromosomal rearrangement); donor-egg cycles (only possible through IVF); surrogacy under the 2021 Act; and carrier couples — for example a thalassemia carrier couple — where PGT-M lets the lab select unaffected embryos.

Findings at diagnostic laparoscopy can also prompt skipping IUI. If laparoscopy reveals significant pelvic adhesions, severe endometriosis with ovarian involvement, or tubal damage not visible on HSG, the IUI prognosis often drops and IVF becomes the better path. Some specialists include diagnostic laparoscopy in the unexplained-infertility workup after 1–2 failed IUI cycles, especially in younger women where surgical findings can change the plan. Laparoscopy costs roughly Rs 30,000–60,000 in private centres as a day-care procedure under general anaesthesia — most contemporary specialists lean toward IVF over laparoscopy in older women but consider it meaningful under age 32–33.

There is also a genuine grey zone where the choice is a value judgement, not a clear medical answer. Couples at 35–37 with unexplained infertility, mild male factor, or borderline ovarian reserve sit here — 2–3 IUI cycles is reasonable, but six is excessive. Couples with PCOS whose ovulation is restored on letrozole are similar: many conceive within 4–6 ovulation-induction cycles, but if they have not by then, the data favour moving on. The key principle is to set a clear IUI ceiling at the start — typically 3–4 cycles, occasionally six in younger couples — and not drift indefinitely cycle after cycle.

Many couples in the grey zone benefit from writing down explicit rules before treatment starts. For example: 'We will do 3 IUI cycles. If we are not pregnant after cycle 3, we start IVF planning the same month, with no further IUI.' Or: 'We will do 4 IUI cycles only if each shows good response; if any cycle responds poorly, we move to IVF immediately.' Pre-committing reduces the inertia of decisions made under emotional pressure after a negative test. Discuss the rule openly with your partner and your specialist so all three of you are aligned.

A per-cycle IUI in private Indian clinics in 2026 typically runs Rs 15,000–30,000 — inclusive of letrozole or clomiphene, 2–3 monitoring scans, the trigger shot, sperm wash and concentration, and the IUI procedure itself. Switching to low-dose injectable gonadotropins instead of oral medication raises the cost to Rs 30,000–50,000, because injectables alone run Rs 15,000–30,000. AIIMS Delhi and similar public ART units offer IUI for roughly Rs 5,000–10,000 — dramatically cheaper — but with the usual 1–3 month public-sector waits between cycles.

A per-cycle IVF cycle in India runs Rs 1.5–3.5 lakh for a fresh own-egg cycle, with ICSI adding Rs 30,000–50,000, PGT-A adding Rs 25,000–50,000 per embryo tested, and a frozen embryo transfer adding Rs 50,000–1,20,000. Public IVF at AIIMS runs Rs 50,000–1 lakh. The cost ratio between IUI and IVF is roughly 1:10 in private centres — meaning six IUI cycles at Rs 25,000 each cost about the same as one IVF cycle at Rs 1.5 lakh. That is a useful mental anchor when deciding how many IUI cycles to commit to.

Cumulative costs over a real journey often surprise couples. A 32-year-old who does four IUI cycles (Rs 1 lakh) then one IVF cycle (Rs 2 lakh) spends Rs 3 lakh over 9–12 months; going straight to IVF would have cost Rs 2 lakh over 2–3 months with similar cumulative success. A 38-year-old who does six IUI cycles (Rs 1.5 lakh) then two IVF cycles (Rs 4 lakh) spends Rs 5.5 lakh over 15–18 months; going straight to IVF would have cost Rs 4 lakh over 4–6 months — with higher success, because she would have started cycles at a younger ovarian age. Think in terms of total time and total money to reasonable cumulative success, not just per-cycle price.

Hidden costs that get missed in early budgeting include the one-time workup (AMH, HSG, semen analysis, day 2–3 hormones, infectious-disease panel for both partners — roughly Rs 8,000–15,000); travel and time off work for 3–6 monitoring visits per cycle; refrigerated storage for gonadotropin injections; luteal-phase progesterone after each transfer (Rs 5,000–10,000); and follow-up scan and beta-hCG testing. For IVF, frozen-embryo storage beyond the first year runs Rs 15,000–30,000 per year and accumulates. Ask your clinic for a full itemised list including these items before signing any package — a clinic that hides them in fine print will surprise you with bills later.

The standard step-up pathway in Indian practice — broadly aligned with the Indian Society for Assisted Reproduction (ISAR) and international guidelines — follows a logical sequence tuned to age and diagnosis. For couples under 35 with unexplained or mild-PCOS infertility: 3–4 cycles of letrozole or clomiphene with timed intercourse (Rs 3,000–8,000 per cycle), then 3–4 IUI cycles with ovulation induction, then IVF if no pregnancy. The whole pre-IVF sequence takes roughly 6–12 months and costs Rs 50,000–1,50,000. Many couples conceive during this sequence and avoid IVF entirely; for those who do not, IVF starts within the same year.

For couples at 35–37, the pathway compresses: 2–3 cycles of ovulation induction with or without IUI, then IVF — with total pre-IVF time ideally under 4–6 months, because each month meaningfully reduces ovarian reserve at this age band. For couples at 38–40, the pathway compresses further: 1–2 IUI cycles maximum (only if cycle conditions are favourable, with mild male factor and a normal HSG), then IVF — or skip IUI entirely. For couples over 40, most specialists recommend going directly to IVF, with a frank early conversation about own-egg versus donor-egg success so the couple can plan financially and emotionally.

The pathway is also modified by specific diagnoses. Both tubes blocked on HSG means no IUI — go to IVF. Severe male factor means IVF with ICSI. Stage 3–4 endometriosis means IVF rather than IUI. A recurrent miscarriage workup may prompt PGT-A IVF even in younger patients. Genetic carrier couples needing PGT-M go straight to IVF. The decision tree is diagnosis-based as much as age-based, and a good specialist explains the whole pathway at the first consultation. If a specialist insists on the same plan for everyone regardless of diagnosis, get a second opinion.

Crucially, the conversation about when to step up should happen at the start, not cycle by cycle. A good fertility specialist will lay out the proposed pathway at the first visit: 'Given your age, AMH, your partner's semen analysis, and your HSG, here is my recommended sequence — three IUI cycles with letrozole, and if no pregnancy by cycle 3, we move to IVF. This is what each cycle costs, this is what cumulative success looks like, and these are the points where we will re-evaluate.' This framing protects you from drift — the situation where each cycle is 'one more try' and a year passes without re-examining the larger plan. Set the ceiling at the start, write it down, and renegotiate consciously rather than by inertia.

IUI cycles are markedly easier to live through. The experience is oral medication for about five days (occasionally injections), 1–2 brief monitoring scans, one trigger injection, a short procedure that feels similar to a pap smear, and the two-week wait. Side effects are mild — hot flushes, mild bloating, the occasional headache from letrozole or mood changes from clomiphene. There is no anaesthesia, no surgery, and little time off work. Many couples can fit an IUI cycle around normal life without family or employer knowing — which matters in Indian contexts where fertility treatment can carry stigma.

IVF cycles are demanding on several fronts. Daily injections at fixed times become non-negotiable appointments, with 4–6 monitoring scans over 8–12 days, the day-of-retrieval requirements (fasting from midnight, someone to accompany you, half a day off for sedation), the brief but psychologically intense transfer day, and the hard two-week wait. Side effects can include OHSS symptoms (bloating, weight gain, abdominal discomfort), mood changes, fatigue and emotional volatility. Most patients need at least one day off for retrieval — ideally 2–3 — and a couple of weeks of reduced physical activity around the transfer; safe activity during IVF is worth discussing with your team.

The cumulative emotional cost differs too. Couples who do 3–4 IUI cycles often describe them as moderately stressful and disappointing if they fail, but recoverable. Couples who do 1–2 IVF cycles often describe them as among the hardest experiences of their adult lives — and the financial weight of IVF amplifies the emotional weight, because spending Rs 2 lakh on a cycle creates a different kind of expectation than spending Rs 20,000. Counselling support — through the clinic or an independent counsellor — matters far more during IVF, and navigating the emotional side of TTC together helps both partners stay aligned.

Practical logistics matter for both pathways: decide who in your life knows you are in treatment (most couples keep it private from extended family but tell one or two close friends); plan around work and travel (IVF especially is hard to fit around international travel or major deadlines); arrange support for retrieval day (you cannot drive yourself home after sedation); and prepare for both outcomes after the test. Preparing only for a positive result is a common emotional trap — acknowledge both in advance with a plan for each. Small kindnesses to yourself across the cycle — comfortable clothes for scans, simple meals stocked at home, a soft pre-test ritual — compound into real coping capacity.

Diagnosis shapes the IUI-versus-IVF decision as much as age does. For unexplained infertility under 35, IUI with ovulation induction achieves around 12–18% per cycle and IVF around 35–45%. For mild PCOS responding to letrozole, IUI achieves 15–20% and IVF 40–50%. For mild male factor (total motile count after wash above 10 million), IUI achieves 10–15% and IVF with or without ICSI 30–40%. For severe male factor (under 5 million), IUI achieves under 5% while IVF with ICSI achieves 30–40%. For both tubes blocked, IUI is essentially zero and IVF stays at the age-band baseline.

Endometriosis adds nuance. Stage 1–2: IUI success is similar to unexplained infertility. Stage 3–4: IUI drops to 5–10% per cycle and IVF success falls 20–30% compared with other diagnoses at the same age. Low AMH under 1.0 with normal cycles: IUI drops to 5–10% per cycle, IVF falls 30–40% versus age-band baseline, and the decision often shifts toward IVF sooner because remaining reserve is limited. High AMH above 4 with PCOS: IVF carries OHSS risk and needs an antagonist protocol with possible freeze-all, but per-cycle success can be very good (40–50% under 35). Diminished reserve with high FSH worsens prognosis for both — and donor egg may need to enter the conversation early.

The decision becomes clearer when you put your specific diagnosis on a matrix with your age. Most specialists, when asked, will give you a personalised per-cycle and cumulative estimate for both pathways. Ask explicitly: 'Given my diagnosis and age, what is my per-cycle live-birth probability for IUI, what is it for IVF, and what is the cumulative probability over three cycles of each? What do you recommend as the step-up plan, and at what point would you say IUI has been tried adequately?' These questions structure the decision rather than leaving it to vague clinic momentum.

Combined diagnoses deserve special attention, because they shift the math more than either factor alone. Mild male factor plus low-normal AMH plus age 35 is a profile where the combined prognosis is meaningfully worse than any single factor — yet many specialists treat it as 'mild male factor' or 'borderline AMH' alone and recommend IUI. The honest combined analysis often points to IVF earlier. The right question is not 'what does each factor mean' but 'what does the combination of all my factors together mean for IUI versus IVF.' If your specialist gives a per-factor breakdown without explaining the combined effect, push for the combined picture or seek a second opinion.

See a fertility specialist after 12 months of regular unprotected sex without conceiving if you are under 35, or after six months if you are 35 or older — and sooner if you already know of a risk factor such as irregular or absent periods, a history of pelvic infection or surgery, known endometriosis, or a partner with a known sperm problem. Earlier evaluation is not over-cautious; it simply protects time, which is the one resource fertility treatment cannot buy back. If you are unsure where to begin, learning to spot the early signs of female infertility can help you decide when to act.

Some patterns in Indian IUI practice are red flags that should make you push back. A clinic recommending 8–10 IUI cycles before considering IVF for a couple in their late 30s is not following good practice — cumulative IUI success plateaus by cycle six, and the time spent is reproductively expensive. A clinic recommending IUI for a woman with both tubes blocked on HSG has either misread the HSG or not read it carefully — ask for clarification. A clinic recommending IUI for severe male factor is recommending a procedure with essentially zero success — push for IVF with ICSI. And a clinic that does not perform a full pre-IUI workup (HSG, AMH, semen analysis with morphology) is operating without the information needed to advise you correctly.

During an IVF stimulation cycle, seek urgent medical care for warning signs of ovarian hyperstimulation syndrome (OHSS): rapid abdominal swelling, weight gain of more than 1 kg in a day, severe abdominal pain, persistent vomiting, breathlessness, or markedly reduced urination. After any embryo transfer or IUI, sudden severe one-sided pelvic pain, shoulder-tip pain, fainting, or heavy bleeding can signal an ectopic pregnancy or another emergency and need immediate assessment. Modern antagonist protocols and freeze-all strategies have made severe OHSS rare at good centres, but knowing the warning signs still matters.

Finally, if you feel rushed, dismissed, or given a one-size-fits-all plan, a second opinion is reasonable and inexpensive — a consultation at an ISAR-member centre typically costs Rs 800–2,500, trivial compared with the cost of an entire wrong pathway. A good specialist welcomes a second opinion; defensiveness about one is itself a quiet red flag.

Donor sperm IUI follows different decision logic from husband-sperm IUI. Donor sperm in India is regulated under the ART Act 2021 — only registered ART banks can supply it, donors must be screened for genetic and infectious disease, identity remains confidential, and commercial donation is banned. Donor sperm IUI in women under 35 with no female factor achieves 15–25% per cycle with cumulative 50–65% over 4–6 cycles — higher than husband-sperm IUI in mild male-factor couples, because donor sperm is pre-screened for quality. Whether you choose donor sperm IUI or donor-sperm IVF depends on female-factor status, age and budget.

Donor egg IVF is a separate pathway, used when the woman's own egg quality or quantity is insufficient — over age 42–45, premature ovarian insufficiency or very low AMH at any age, repeated failed own-egg cycles, serious genetic conditions, or ovarian failure after chemotherapy or surgery. Donor egg IVF in India costs roughly Rs 2–4 lakh and achieves 45–55% live birth per transfer regardless of recipient age (within the ART Act eligibility limit). Donor egg cycles are IVF by nature — IUI is not possible, because the egg comes from outside the body. This is one of the most personal conversations in fertility care, and good counselling support is essential.

Advanced female age (over 40–42) reshapes the decision dramatically. At 41 with own eggs, per-cycle IUI success is under 3% and IVF is 8–15% — cumulative three-cycle IVF gives 25–35% live birth, while cumulative six-cycle IUI gives perhaps 10–15%. Donor egg at 41 gives 45–55% per transfer. The honest conversation at this age is between three options: own-egg IVF with full awareness of low per-cycle success and high cancellation risk; donor-egg IVF with high success but the personal complexity of donor genetic material; or stopping treatment and choosing adoption or a child-free life. IUI is rarely the right answer over 40.

Same-sex female couples and single women face an added layer in India, because the ART Act 2021 currently restricts services to married heterosexual couples and to widowed or divorced single women — leaving unmarried single women, same-sex couples and live-in partners without legal access to ART within India. Some travel abroad where the framework is more inclusive, often spending Rs 5–15 lakh including travel; others have pursued legal challenges, with cases pending in the High Courts and the Supreme Court at the time of writing. For couples in this position, the adoption pathway through CARA is another route to parenthood worth understanding. This remains a real and unresolved gap in Indian reproductive law.

• WHO — Infertility (key facts and definitions)
• NICE — Fertility problems: assessment and treatment (guideline CG156)
• ACOG — Treating Infertility (FAQ)
• ASRM — Intrauterine Insemination (IUI) patient resources
• ICMR / MoHFW — The Assisted Reproductive Technology (Regulation) Act, 2021
• NHS — IVF: overview